Roche’s enicepatide helps patients with type 2 diabetes lose weight
Roche said its experimental obesity drug enicepatide helped patients with type 2 diabetes lose weight and lower blood sugar in a mid-stage clinical trial.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.